Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion

Antimicrobial resistance represents a serious threat for global health, causing an unacceptable burden in terms of morbidity, mortality and healthcare costs. In particular, in 2017, carbapenem-resistant organisms were listed by the WHO among the group of pathogens for which novel treatment strategie...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppola, Nicola, Maraolo, Alberto Enrico, Onorato, Lorenzo, Scotto, Riccardo, Calò, Federica, Atripaldi, Luigi, Borrelli, Anna, Corcione, Antonio, De Cristofaro, Maria Giovanna, Durante-Mangoni, Emanuele, Filippelli, Amelia, Franci, Gianluigi, Galdo, Maria, Guglielmi, Gaspare, Pagliano, Pasquale, Perrella, Alessandro, Piazza, Ornella, Picardi, Marco, Punzi, Rodolfo, Trama, Ugo, Gentile, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495208/
https://www.ncbi.nlm.nih.gov/pubmed/36140042
http://dx.doi.org/10.3390/antibiotics11091263
Descripción
Sumario:Antimicrobial resistance represents a serious threat for global health, causing an unacceptable burden in terms of morbidity, mortality and healthcare costs. In particular, in 2017, carbapenem-resistant organisms were listed by the WHO among the group of pathogens for which novel treatment strategies are urgently needed. Fortunately, several drugs and combinations have been introduced in recent years to treat multi-drug-resistant (MDR) bacteria. However, a correct use of these molecules is needed to preserve their efficacy. In the present paper, we will provide an overview on the epidemiology and mechanisms of resistance of the most common MDR Gram-negative bacteria, proposing a treatment algorithm for the management of infections due to carbapenem-resistant bacteria based on the most recent clinical evidence.

Ejemplares similares